Nasal Covid vaccine shows promise in early clinical trial

Written By Bluelake Biotechnology

https://www.nbcnews.com/health/health-news/nasal-covid-vaccine-shows-promise-early-clinical-trial-rcna71841

Bluelake Biotechnology
Previous

How a nasal vaccine could reduce the risk of COVID infections — and new variants
Next

Blue Lake Biotechnology to highlight preliminary COVID Phase 1 data at BIO CEO Conference